Literature DB >> 32210394

TRAIL regulates T cell activation and suppresses inflammation in autoimmune diseases.

I-Tsu Chyuan1,2, Ping-Ning Hsu3,4.   

Abstract

Entities:  

Year:  2020        PMID： 32210394      PMCID： PMC7784853          DOI： 10.1038/s41423-020-0410-2

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  24 in total

1.  Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Authors:  H Walczak; R E Miller; K Ariail; B Gliniak; T S Griffith; M Kubin; W Chin; J Jones; A Woodward; T Le; C Smith; P Smolak; R G Goodwin; C T Rauch; J C Schuh; D H Lynch
Journal:  Nat Med       Date:  1999-02       Impact factor: 53.440

Review 2.  Th17 plasticity and its relevance to inflammatory bowel disease.

Authors:  Aito Ueno; Louisa Jeffery; Taku Kobayashi; Toshifumi Hibi; Subrata Ghosh; Humberto Jijon
Journal:  J Autoimmun       Date:  2017-12-28       Impact factor: 7.094

3.  Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.

Authors:  G S Wu; T F Burns; Y Zhan; E S Alnemri; W S El-Deiry
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

4.  Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

Authors:  Orhan Aktas; Alina Smorodchenko; Stefan Brocke; Carmen Infante-Duarte; Ulf Schulze Topphoff; Johannes Vogt; Timour Prozorovski; Susanne Meier; Venera Osmanova; Elena Pohl; Ingo Bechmann; Robert Nitsch; Frauke Zipp
Journal:  Neuron       Date:  2005-05-05       Impact factor: 17.173

5.  Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.

Authors:  B Hilliard; A Wilmen; C Seidel; T S Liu; R Göke; Y Chen
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

6.  An antagonist decoy receptor and a death domain-containing receptor for TRAIL.

Authors:  G Pan; J Ni; Y F Wei; G Yu; R Gentz; V M Dixit
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

7.  An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis.

Authors:  I-Tsu Chyuan; Hwei-Fang Tsai; Hsiu-Jung Liao; Chien-Sheng Wu; Ping-Ning Hsu
Journal:  Cell Mol Immunol       Date:  2017-04-10       Impact factor: 11.530

Review 8.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

9.  The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.

Authors:  M F Neurath; B Weigmann; S Finotto; J Glickman; E Nieuwenhuis; H Iijima; A Mizoguchi; E Mizoguchi; J Mudter; P R Galle; A Bhan; F Autschbach; B M Sullivan; S J Szabo; L H Glimcher; R S Blumberg
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

10.  TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.

Authors:  I-Tsu Chyuan; Hwei-Fang Tsai; Chien-Sheng Wu; Chi-Chang Sung; Ping-Ning Hsu
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561
View more
  1 in total

1.  TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas.

Authors:  Huanyu Zhang; Guohui Qin; Chaoqi Zhang; Huiyun Yang; Jinyan Liu; Hongwei Hu; Peng Wu; Shasha Liu; Li Yang; Xinfeng Chen; Xueke Zhao; Lidong Wang; Yi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.